Page 4 - Biocon Biologics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biocon biologics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biocon Biologics Today - Breaking & Trending Today

First Aflibercept Biosimilars Approved in US

The FDA approved the first 2 biosimilars referencing aflibercept (Eylea). (aflibercept). However, patent litigation has left it unclear when the biosimilars will come to market. ....

United States , Samsung Bioepis , Biocon Biologics Yesafili , Biocon Biologics , Cardinal Health , European Commission , European Union , Syda Productions , United Kingdom ,

Interchangeable Biosimilar to Eylea Get FDA Approval

Both approvals were supported by comparative clinical trials, as well as studies that evaluated the products on an analytical level using physicochemical tests and biological assays. ....

Biocon Biologics , Yesafili Clinicaltrials , Samsung Bioepis , Drug Administration ,

Biocon Biologics secures USFDA approval for biosimilar product to treat ophthalmology conditions

The US Food and Drug Administration (USFDA) has approved the company s first-to-file application for Yesafili, a vascular endothelial growth factor inhibitor used to treat several different types of ophthalmology conditions, the company said in a statement. ....

United States , Shreehas Tambe , Biocon Biologics , Drug Administration , Biocon Ltd , Director Shreehas Tambe ,

Biocon Biologics gets US FDA approval for biosimilar aflibercept Yesafili, enters US ophthalmology market

International Business News: NEW DELHI: Biocon Biologics announced that the US Food and Drug Administration (US FDA) has approved the company's application for YESAFILI, the compa. ....

United States , Matt Erick , Shreehas Tambe , Biosimilar Aflibercept , Biocon Biologics , Drug Administration , Biologic Obtains , Chief Commercial Officer ,